Sepsis on Cruise Ships — Recognition, Resuscitation and Escalation at Sea

Last updated: May 2026

Introduction: Sepsis at Sea — A Time-Critical Condition Without ICU Backup

Sepsis kills by the hour. In a hospital, that statement triggers a cascade of resources: blood cultures are drawn in the emergency department, broad-spectrum antibiotics are administered within sixty minutes, arterial lines are placed for continuous blood pressure monitoring, central venous access is established, lactate is trended every two hours, and the intensive care team is called when organ dysfunction escalates beyond the capacity of the ward. The infrastructure of a modern hospital is designed to compress the interval between recognition and definitive treatment into the narrowest possible window.

In the ship medical centre, that infrastructure does not exist. There is no ICU. There is no intensivist on call. There is no arterial line, no central venous pressure monitor, no vasopressor infusion pump calibrated to micrograms per kilogram per minute. The laboratory consists of a point-of-care analyser that may or may not include lactate. The pharmacy is a locked cupboard with a limited formulary. The nursing team is one or two nurses who are simultaneously managing every other patient in the medical centre. And the nearest hospital may be twelve, twenty-four, or forty-eight hours away by sea.

This is the reality of managing sepsis on a cruise ship. The pathophysiology is identical to what you learned in medical school. The clinical urgency is identical. But the resources are not, and the gap between what the patient needs and what the ship can provide defines every decision you will make from the moment you recognise the syndrome.

Sepsis at sea is not a different disease. It is the same disease in a radically different context — and that context changes everything about how you manage it.

Early Recognition: NEWS2, qSOFA and Sepsis Screening in the Ship Medical Centre

Early recognition is the single most important intervention in sepsis, and it is the one intervention that costs nothing in terms of equipment or supplies. It requires only vigilance, a structured approach, and the discipline to screen every unwell patient for the possibility of infection-driven organ dysfunction.

The National Early Warning Score 2 (NEWS2), developed by the Royal College of Physicians, is the recommended screening tool for acutely unwell patients in the UK and is ideally suited to the ship medical centre. It aggregates six physiological parameters — respiratory rate, oxygen saturation, systolic blood pressure, pulse rate, level of consciousness, and temperature — into a single composite score. Every parameter can be measured with equipment available on any cruise ship. No laboratory result is required. The score can be calculated in under two minutes.

The NEWS2 trigger thresholds that should prompt you to consider sepsis:

• Score of 5 or above: Urgent clinical review required. In the context of suspected infection, this should trigger the sepsis pathway.
• Score of 7 or above: Emergency response. This patient is critically unwell and needs immediate intervention. In a hospital, this would trigger a medical emergency team call. On a ship, it triggers everything you have.
• Any single parameter scoring 3: Even if the aggregate score is low, a single extreme value — for example, a respiratory rate above 25 or a systolic blood pressure below 91 — should raise suspicion for sepsis in the context of infection.

The quick Sequential Organ Failure Assessment (qSOFA) is a complementary bedside tool. It uses three criteria: respiratory rate of 22 or above, altered mentation (Glasgow Coma Scale below 15), and systolic blood pressure of 100 mmHg or below. A qSOFA score of 2 or more identifies patients at high risk of poor outcomes from sepsis. It is deliberately simple — no laboratory values, no equipment beyond a blood pressure cuff and a clock — and it was designed for exactly the kind of resource-limited setting that a ship medical centre represents.

The practical approach for the ship doctor is to use NEWS2 as your primary screening tool for all acutely unwell patients, and to layer qSOFA on top when infection is suspected. If a patient presents with a plausible source of infection and either a NEWS2 score of 5 or above or a qSOFA of 2 or above, you are managing presumed sepsis until proven otherwise. Do not wait for confirmatory investigations. The clock is already running.

The Sepsis Six at Sea: Adapted for Limited Resources

The Sepsis Six bundle, originally developed by the UK Sepsis Trust, provides a structured framework for the first hour of sepsis management. In a hospital, all six elements can typically be completed within sixty minutes. On a ship, some elements require adaptation, and the order of priority may shift based on what you have available.

The six elements, adapted for the maritime setting:

1. Give high-flow oxygen. Target an SpO2 of 94–98% (or 88–92% in known COPD). Use a non-rebreather mask at 15 litres per minute if the patient is critically unwell. But remember the oxygen clock — conduct a burn-rate audit immediately and titrate to the lowest effective flow rate once the patient is stabilised. Your oxygen supply is finite, and sepsis patients may need it for days.
2. Take blood cultures. This is where maritime medicine diverges sharply from hospital practice. Most ship medical centres do not carry blood culture bottles. If you do not have them, document that cultures were not available and proceed. Do not delay antibiotics to search for equipment you do not have. If you carry culture bottles, take two sets from two different sites before the first antibiotic dose. This is the only window in which cultures are meaningful.
3. Give intravenous antibiotics. This is the most time-critical intervention you can control. Administer the first dose of empiric antibiotics as rapidly as possible — the target is within one hour of sepsis recognition. Antibiotic selection is discussed in detail below, but the principle is simple: broad-spectrum coverage of the most likely source, given immediately, is more valuable than the perfect antibiotic given late.
4. Give intravenous fluids. Start with a 500 ml bolus of crystalloid over 15 minutes. Reassess. Repeat if the patient remains hypotensive or shows signs of inadequate perfusion. The Surviving Sepsis Campaign recommends at least 30 ml/kg within the first three hours for sepsis-induced hypoperfusion. Fluid strategy is discussed further below.
5. Measure lactate. If your point-of-care analyser includes lactate, measure it at presentation and repeat at two and four hours. A lactate above 2 mmol/L supports the diagnosis of sepsis-induced tissue hypoperfusion. A lactate above 4 mmol/L indicates severe sepsis with a significantly elevated mortality risk. If you do not have lactate measurement capability, document the gap and rely on clinical markers of perfusion: capillary refill time, urine output, level of consciousness, and mottling.
6. Measure urine output. Insert a urinary catheter and commence hourly urine output monitoring. This is one of the most valuable monitoring tools available on a ship, because it requires no special equipment beyond a catheter and a measuring jug. Target urine output of at least 0.5 ml/kg/hour. Falling urine output is one of the earliest signs of renal hypoperfusion and should trigger reassessment of fluid status and perfusion.

The Sepsis Six at sea is not about doing six things perfectly. It is about doing the six things you can do, documenting the things you cannot, and not allowing the absence of one element to delay the others.

Fluid Resuscitation: Crystalloid Selection and Monitoring Without Invasive Lines

Fluid resuscitation in sepsis is simultaneously straightforward in principle and treacherous in execution. The principle is simple: sepsis causes vasodilation and capillary leak, leading to effective hypovolaemia and tissue hypoperfusion. Fluid restores intravascular volume. The treachery lies in knowing when enough is enough, because over-resuscitation causes pulmonary oedema, worsens oxygenation, and increases mortality — and the tools that hospitals use to guide fluid balance (central venous pressure, arterial waveform analysis, echocardiography) are not available on a ship.

Crystalloid selection: The Surviving Sepsis Campaign recommends balanced crystalloids (Hartmann's solution or Plasmalyte) over 0.9% normal saline for initial resuscitation. Normal saline carries a risk of hyperchloraemic metabolic acidosis when given in large volumes, which can confound clinical assessment and worsen renal function. Most ship medical centres stock normal saline. If Hartmann's solution is available, use it preferentially. If only normal saline is available, use it without hesitation — the risk of under-resuscitation far exceeds the risk of hyperchloraemia in the first few hours.

Initial resuscitation: Begin with a 500 ml bolus over 15 minutes. Reassess heart rate, blood pressure, capillary refill time, and conscious level after each bolus. If the patient remains hypotensive or tachycardic, give a second bolus. Continue in 500 ml increments, reassessing after each, until blood pressure improves, capillary refill normalises, or you reach 30 ml/kg. Beyond 30 ml/kg, be increasingly cautious — each additional bolus carries a greater risk of fluid overload.

Monitoring response without invasive lines: In the absence of CVP lines or arterial monitoring, you must rely on clinical assessment. The key markers are:

• Mean arterial pressure (MAP): Target MAP of 65 mmHg or above. Most automatic blood pressure cuffs display MAP. If yours does not, calculate it: MAP = diastolic + one-third of (systolic minus diastolic).
• Capillary refill time: Press the sternum for five seconds and release. Normal refill is under two seconds. Prolonged capillary refill indicates inadequate peripheral perfusion.
• Urine output: The single most reliable indicator of renal perfusion available on a ship. Measure hourly. Target 0.5 ml/kg/hour minimum.
• Heart rate trend: A falling heart rate in response to fluid suggests improving preload. A persistently elevated heart rate despite adequate fluid volume suggests either ongoing sepsis, inadequate source control, or the need for vasopressor support.
• Passive leg raise: Lift the patient's legs to 45 degrees for one minute and measure the blood pressure response. An increase of 10% or more in pulse pressure suggests the patient is fluid-responsive and may benefit from further boluses. This is a simple, non-invasive test that can be performed repeatedly.

Antibiotic Selection: The Ship Medical Centre Formulary

The antibiotics available on a cruise ship are determined by flag state regulations, company medical directors, and the practical constraints of storage and shelf life. Most ship medical centres carry a formulary that is adequate for empiric sepsis coverage, but the range is narrower than a hospital pharmacy, and resupply may not be possible for days.

Typical ship medical centre antibiotics relevant to sepsis management include:

• Co-amoxiclav (Augmentin) IV: Broad-spectrum coverage of community-acquired respiratory, urinary, and intra-abdominal infections. This is often the workhorse antibiotic on a ship and a reasonable first-line choice for undifferentiated sepsis.
• Ceftriaxone IV: Third-generation cephalosporin with excellent gram-negative coverage. Particularly useful for urinary sepsis, pneumonia, and meningitis. The advantage of ceftriaxone is once-daily dosing, which reduces nursing workload — a significant consideration when you have one or two nurses managing the entire medical centre.
• Metronidazole IV: Anaerobic coverage. Add to co-amoxiclav or ceftriaxone when intra-abdominal sepsis is suspected, particularly if there is concern about perforated viscus or severe diverticulitis.
• Gentamicin IV: Aminoglycoside with potent gram-negative activity. Useful as a synergistic agent in severe sepsis, but requires careful dosing and monitoring. Without reliable renal function testing, use with caution and reserve for life-threatening situations where other options have failed.
• Ciprofloxacin IV/PO: Fluoroquinolone with broad gram-negative coverage. Useful for urinary sepsis and as a step-down oral option when the patient improves.
• Flucloxacillin IV: Anti-staphylococcal penicillin. First-line for skin and soft tissue infections with suspected staphylococcal involvement — cellulitis, wound infections, abscess-related sepsis.

Empiric regimens by suspected source:

• Undifferentiated sepsis / no clear source: Co-amoxiclav 1.2 g IV three times daily. Alternatively, ceftriaxone 2 g IV once daily.
• Urinary sepsis: Ceftriaxone 2 g IV once daily. Add gentamicin (5 mg/kg IV once daily) if severely unwell.
• Pneumonia: Co-amoxiclav 1.2 g IV three times daily. Consider adding clarithromycin 500 mg IV twice daily for atypical coverage if available.
• Skin and soft tissue: Flucloxacillin 2 g IV four times daily. If rapidly progressive or suspecting necrotising fasciitis, add ceftriaxone and metronidazole and arrange immediate medevac.
• Intra-abdominal: Ceftriaxone 2 g IV once daily plus metronidazole 500 mg IV three times daily.
• Gastroenteritis-related sepsis: Ceftriaxone 2 g IV once daily. Consider ciprofloxacin if enteric gram-negative organisms are the primary concern.

The cardinal rule is speed over specificity. An imperfect antibiotic given within the first hour saves more lives than the perfect antibiotic given at hour three. Administer the best available option immediately, document your reasoning, and adjust if cultures or clinical response provide further information.

When Resources Run Out: Managing Sepsis with Limited Supplies

A hospital never runs out of normal saline during a resuscitation. A ship can. IV fluid supplies are finite, IV antibiotics have a limited stock, and the physical space of the medical centre constrains how many infusions can run simultaneously. The ship doctor must plan for the possibility that resources will not stretch to meet the clinical demand.

Practical strategies for resource-limited sepsis management:

• Fluid conservation: After the initial resuscitation phase, switch to a maintenance strategy rather than continued aggressive bolusing. Use clinical endpoints (urine output, capillary refill) to guide further fluid administration rather than protocol-driven volumes.
• Oral switch: As soon as the patient can tolerate oral intake and is showing clinical improvement, switch from IV to oral antibiotics. Oral bioavailability of ciprofloxacin, metronidazole, and co-amoxiclav is excellent. Early oral switch preserves IV stock for deterioration scenarios.
• Medication inventory: At the point of sepsis recognition, audit your remaining stock of antibiotics, IV fluids, and vasopressors. Calculate how many days of treatment your stock supports at the current regimen. If the stock will not last until the next port or medevac, this is a capability gap that must be communicated to the bridge immediately.
• Rationing oxygen: Sepsis patients who are hypoxic may require supplemental oxygen for days. Conduct a burn-rate audit and titrate to the lowest effective SpO2 target. Accept a target of 92% rather than 96% if oxygen supply is critically limited.
• Improvised monitoring: If electronic monitoring equipment fails or is occupied, manual observations every 15 to 30 minutes — pulse, respiratory rate, blood pressure, capillary refill, conscious level, and urine output — provide clinically adequate surveillance. Document on paper if electronic records are unavailable.

Vasopressor Use at Sea: Noradrenaline via Peripheral Access

Vasopressor therapy represents the ceiling of what a ship medical centre can offer in terms of critical care. Traditionally, noradrenaline (norepinephrine) has been considered a drug that requires central venous access and intensive care monitoring. At sea, central venous access is rarely available, and the alternative — watching a patient die of refractory septic shock while a vasopressor sits in the cupboard — is unacceptable.

Recent evidence and guidelines, including consensus statements from the European Society of Intensive Care Medicine, support the short-term use of dilute noradrenaline via peripheral intravenous access in emergency situations where central access is not available. This is directly applicable to the maritime setting.

When to consider peripheral noradrenaline:

• The patient has received at least 30 ml/kg of crystalloid and remains hypotensive (MAP below 65 mmHg).
• The patient shows signs of end-organ hypoperfusion despite fluid resuscitation: altered consciousness, mottled skin, urine output below 0.5 ml/kg/hour.
• Central venous access is not available or cannot be placed safely.
• The clinical trajectory suggests the patient will deteriorate further without vasopressor support.

Practical considerations for peripheral noradrenaline at sea:

• Concentration: Use a dilute solution. The recommended concentration for peripheral administration is 16 micrograms/ml (4 mg in 250 ml of 5% dextrose or normal saline).
• Access: Use a large-bore cannula (18G or larger) in a large proximal vein — antecubital fossa or external jugular. Avoid hand and wrist veins, as extravasation in these areas carries a higher risk of tissue necrosis.
• Monitoring: Check the cannula site every 15 minutes for signs of extravasation: swelling, blanching, pain at the site. Any sign of extravasation mandates immediate cessation of the infusion through that line.
• Duration: Peripheral noradrenaline is a bridge, not a destination. It buys time for medevac or diversion. If you are running peripheral noradrenaline, the patient has exceeded the capability of the ship medical centre and evacuation planning should already be underway.
• Infusion control: If an infusion pump is available, use it. If not, titrate by drop rate with extreme caution and frequent blood pressure checks. Start at a low rate and increase every five minutes until MAP reaches 65 mmHg.

Peripheral noradrenaline at sea is not ideal practice. It is emergency practice. It exists to prevent death during the interval between recognition of refractory shock and arrival of definitive care.

The Medevac Decision: When Sepsis Severity Exceeds Shipboard Capability

Not every patient with sepsis needs to be evacuated from the ship. Many patients with early sepsis — a urinary tract infection with mild systemic features, a pneumonia responding to antibiotics within the first twelve hours — can be managed safely in the ship medical centre with close observation and serial reassessment. The medevac decision in sepsis is not triggered by the diagnosis itself but by the trajectory.

Indicators that medevac or urgent diversion should be initiated:

• Refractory hypotension: MAP below 65 mmHg despite 30 ml/kg or more of crystalloid, requiring vasopressor support.
• Respiratory failure: Oxygen requirement above 10 litres per minute, or SpO2 below 92% despite maximal available oxygen therapy. This is a dual trigger: clinical deterioration and the oxygen clock.
• Deteriorating consciousness: GCS falling below 12, or any patient requiring airway protection that the ship medical centre cannot provide long-term.
• Suspected surgical source: Perforated viscus, necrotising fasciitis, or any condition requiring operative intervention that cannot be performed on board.
• Rising lactate: If lactate measurement is available and shows a rising trend despite treatment, this indicates ongoing tissue hypoperfusion that is not responding to shipboard interventions.
• Resource exhaustion: Projected depletion of IV fluids, antibiotics, oxygen, or vasopressors before the ship reaches port.
• Clinical deterioration despite 6 hours of optimal treatment: If the patient has received the full Sepsis Six bundle and is not improving at the six-hour reassessment, the probability of requiring interventions beyond shipboard capability is high.

The medevac request should be structured, include a clear clinical summary, and quantify the capability gap. Use the SBAR-M template to ensure the receiving team and coordination centre understand both the clinical severity and the logistical constraints. Document the decision, the clinical rationale, and the time of request in the patient record.

Bridge Communication: Using SBAR-M for Sepsis Emergencies

Sepsis emergencies frequently require bridge-level decisions: speed changes, course diversions, helicopter landing preparations, or coordination with maritime rescue services. The bridge team does not have a medical background. They need information that is structured, concise, and actionable. The SBAR-M framework (Situation, Background, Assessment, Recommendation, Maritime context) provides this structure.

An example SBAR-M for a sepsis emergency:

• Situation: I have a 68-year-old male passenger with sepsis from a urinary infection. He is currently on IV antibiotics and fluid resuscitation. His blood pressure is not responding to treatment.
• Background: He presented six hours ago with fever and confusion. He has received three litres of IV fluid and two doses of antibiotics. His blood pressure remains low at 80/50.
• Assessment: This patient has septic shock that is not responding to the treatment available on board. He requires intensive care facilities that we cannot provide. Without vasopressor support and invasive monitoring, I expect further deterioration.
• Recommendation: I recommend we divert to the nearest port with a hospital capable of intensive care, or request helicopter evacuation if within range. The patient needs to be in a hospital within the next twelve hours.
• Maritime context: Our IV fluid supply will last approximately eighteen hours at the current rate. Oxygen supply is adequate for thirty-six hours. The patient cannot be moved by stretcher to a helicopter in his current condition without significant risk. We need a winch-capable aircraft or port-side ambulance transfer.

Deliver this communication in person to the officer of the watch or the captain. Follow it with a written summary for the ship's log. Document the time of communication, the name and rank of the officer you spoke to, and their response. This documentation is critical for medicolegal protection and for demonstrating that capability gaps were communicated transparently and in a timely manner.

Documentation: Serial Observations, Treatment Timeline and Capability Gap Records

Documentation in maritime sepsis management serves three purposes: clinical continuity, medicolegal protection, and evidence that the standard of care was met within the constraints of the environment. The documentation must tell the story of a clinician who recognised the emergency, acted within the limits of available resources, and communicated transparently when those limits were reached.

Essential documentation elements:

• Time of recognition: When was sepsis first suspected? What triggered the suspicion (NEWS2 score, clinical presentation, specific vital sign abnormality)?
• Sepsis Six timeline: Document the time each element of the Sepsis Six was initiated. If an element was not available (for example, blood cultures), document why.
• Serial observations: Record vital signs at least every 30 minutes during the acute phase, including heart rate, blood pressure, respiratory rate, SpO2, temperature, GCS, and urine output. Frequency can be reduced to hourly once the patient stabilises.
• Fluid balance: Document every fluid bolus with the time, volume, type, and the clinical response observed after administration.
• Antibiotic administration: Drug, dose, route, and time for every antibiotic dose.
• Capability gap documentation: Use the capability gap note template to formally record what the patient needs that the ship cannot provide. This is not an admission of failure — it is a professional record of the environmental constraints that shaped clinical decisions.
• Bridge communication log: Time, recipient, content summary, and response for every communication with the bridge regarding the patient.
• Medevac request log: If medevac is requested, document the time, the agency contacted, the clinical information provided, and the response received.

Common Sources of Sepsis on Ships

The sources of sepsis on cruise ships reflect the demographics of the passenger population (frequently elderly with multiple comorbidities), the close-quarters living environment, and the exposures inherent to maritime travel. Understanding the common sources helps direct empiric antibiotic selection and guides the focused clinical assessment.

• Urinary tract infections: The most common source of sepsis in the elderly passenger population. Dehydration from travel, reduced fluid intake, and pre-existing urological conditions contribute. Presentation may be atypical in older patients — confusion without dysuria is a classic trap. Empiric coverage with ceftriaxone is usually appropriate.
• Pneumonia: Both community-acquired and aspiration pneumonia are common. The ship environment, with recirculated air and close contact in dining areas and entertainment venues, facilitates respiratory pathogen transmission. Elderly passengers with swallowing difficulties are at particular risk of aspiration. Legionella should be considered if the ship's water systems are implicated.
• Skin and soft tissue infections: Cellulitis, wound infections, and infected insect bites can progress to sepsis, particularly in diabetic or immunocompromised passengers. Crew members are at risk from occupational injuries — cuts, burns, and crush injuries in the galley, engine room, or deck operations. Staphylococcal and streptococcal coverage with flucloxacillin is first-line.
• Gastroenteritis-related sepsis: Norovirus outbreaks are well-publicised, but bacterial gastroenteritis (Salmonella, Campylobacter, Shigella) can progress to invasive disease and sepsis, particularly in the elderly or immunocompromised. Severe dehydration from gastroenteritis can mimic or trigger sepsis-like presentations. Gram-negative coverage with ceftriaxone or ciprofloxacin is appropriate.
• Wound infections: Post-procedural infections (after suturing in the medical centre), marine envenomation wounds, and coral cuts are specific maritime risks. Marine wound infections carry unusual organisms including Vibrio species, which require specific antibiotic coverage (doxycycline plus ceftriaxone). Any wound sustained in seawater that develops surrounding erythema and systemic features should raise immediate suspicion for Vibrio infection.
• Biliary and intra-abdominal sepsis: Cholecystitis, diverticulitis, and appendicitis can all progress to peritonitis and sepsis. These are surgical conditions that the ship cannot manage definitively, and sepsis from an intra-abdominal source should trigger early medevac planning alongside antibiotic therapy.

References

• Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Intensive Care Medicine. 2021;47(11):1181–1247.
• Royal College of Physicians. National Early Warning Score (NEWS) 2: Standardising the assessment of acute-illness severity in the NHS. RCP, 2017.
• Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810.
• UK Sepsis Trust. The Sepsis Six. Available at: sepsistrust.org.
• Royal College of Emergency Medicine. Sepsis toolkit — clinical guidance. RCEM, 2022.
• Maritime and Coastguard Agency (MCA). Ship Captain's Medical Guide. 23rd edition. London: The Stationery Office.
• Loubani OM, Green RS. A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. Journal of Critical Care. 2015;30(3):653.e9–17.
• Cardenas-Garcia J, Schaub KF, Belchikov YG, et al. Safety of peripheral intravenous administration of vasoactive medication. Journal of Hospital Medicine. 2015;10(9):581–585.

Continue Reading

• Oxygen Is a Clock at Sea
• The 72-Hour Maritime ICU Problem
• Why Ship Doctors Need Bridge Phrases
• When the Patient Is Stable but the Ship Is Not
• Cruise Ship Outbreaks Are Operational Events